YS Biopharma Co., Ltd.
Earnings Date & Report
Last updated:
YS Biopharma Co., Ltd.’s last earnings date was on 22 Apr 2024.
YS Biopharma Co., Ltd. stock Earnings report, Estimates & History
| 2024-01-22 | -0.72 | -0.16 |
|---|
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
YS Biopharma Co., Ltd. stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 22 Apr 2024 | N/A | N/A | N/A | N/A | N/A | |
| 22 Jan 2024 | Beat | -$0.72 | -$0.16 | N/A | N/A | |
| 4 Dec 2023 | N/A | N/A | $0.22 | N/A | 96.81M | |
| 13 Nov 2023 | N/A | N/A | $0.22 | N/A | N/A | |
| 15 Aug 2023 | N/A | N/A | -$0.1 | N/A | 176.27M | |
| 30 Jun 2023 | N/A | N/A | $0.28 | N/A | N/A | |
| 12 May 2023 | N/A | N/A | $0.28 | N/A | N/A | |
| 30 Mar 2023 | N/A | N/A | $0.23 | N/A | N/A | |
| 30 Sep 2022 | N/A | N/A | $0.09 | N/A | 194.05M | |
| 30 Jun 2022 | N/A | N/A | -$0.21 | N/A | 205.47M | |
YS Biopharma Co., Ltd. Earnings report FAQs
When is YS Biopharma Co., Ltd.'s next Earnings date?
The company has not set the next earnings date yet. The latest YS Biopharma Co., Ltd.'s earnings date was on 15 Aug 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.